Company Overview and News
Over the last five trading days, bank stocks have put up a lackluster show. Mortgage rates declined in the week, hitting 4.57%, along with bond yields, on escalating U.S.-China trade war fears. Further, the benchmark 10-year Treasury yield shrunk during this week, as demand for safe-haven assets increased. On the other hand, on Thursday, the Federal Reserve released the Dodd-Frank Act supervisory stress test 2018 (DFAST 2018) results, which, to a great extent, reflect stability in the banking system.
WFCNP COF.PRG COF.PRH COF.WS WFC.PRL COF.PRP WFC.PRJ USB COF-D WFC.PRT COF-C COF-F WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX COF.PRC COF.PRD WFC.PRW WFC.PRV COF.PRF WFC WFC.WS C COF-P COF
Bank of America Corp (NYSE:BAC) has been a stellar performer over the past seven years. From $6/share as recently as early 2012, Bank of America stock has launched upward. With the stock around $30 now, anyone holding since then is sitting on a quintuple. Even since the 2016 low around $13, the stock has more than doubled.
WFC WFCNP WFC.WS NYCB.PRA WFC.PRL NYCB.PRU WFC.PRJ BAC USB WFC.PRT WFC.PRR WFC.PRQ WFC.PRP JPM WFC.PRO WFC.PRN NYCB WFC.PRY WFC.PRX WFC.PRW WFC.PRV
This is the first article of a new monthly series covering a model dividend-growth portfolio I created. What makes this portfolio different, is it has some attributes that are not present in other dividend-growth portfolios here on Seeking Alpha. In my search, I look for companies with a minimum 2% yield that have solid fundamentals, which is no different from many other dividend-growth portfolios.
Bank of America Corporation (BAC - Free Report) and U.S. Bancorp (USB - Free Report) reported first-quarter earnings results on Apr 16 and Apr 18, respectively. While Bank of America’s first-quarter earnings per share and revenues outpaced their respective estimates, U.S. Bancorp managed to beat its bottom-line estimate by only a cent, while missing on the top line.
JBK BAC GS.PRICL GSC TFG GS.PRB GS.PRA GSJ BAC USB GS.PRJ GS.PRI GS GLSSP GS.PRD GS.PRC GJS GS.PRN GS.PRK
Amazingly, summer is almost here, and the second quarter is down to the last month. One thing is certain: as we move into the typically slower trading months, 2018 could very well end up being a year in which the market highs already have been set. So it makes sense to look at companies, especially in the financial sector, that aren’t trading at rich multiples or 52-week highs.
WFCNP DB GS.PRB MS.PRE WFC.PRL GS.PRA MS.PRF WFC.PRJ MS.PRG MS.PRA USB WFC.PRT GS WFC.PRR GLSSP WFC.PRQ WFC.PRP WFC.PRO WFC.PRN MS WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS JBK GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI MS.PRI GS.PRD MS.PRK GS.PRC GJS GS.PRN GS.PRK
The largest five individual stock positions are Cisco Systems, Berkshire Hathaway, Baidu Inc., Johnson & Johnson, and Alphabet, and they account for ~49% of the portfolio.
NOW PSX AZO RDSB TOT RDSA MRC RHHBF HSB RHHVF NWLI AMZN CSCO EMR CMCSK MMM WPP CTWS TMK HCS BRK.A AVT HEIO JNJ BK GOOGL RYDBF VZ NVS WFCNP AXELF HAL PM TMK WSM MTSI CCV DVN WFC.PRL AXP CCZ WFC.PRJ GOOG BAX SHEN VZA COP USB WFC.PRT CKX KOF WFC.PRR TMK.PRC WFC.PRQ ANAT TMK.PRB WFC.PRP WFC.PRO WFC.PRN JEF WFC.PRY RYDAF HSBC.PRA WFC.PRX BIDU HSBC WFC.PRW DEO WFC.PRV AGCO HBCYF WFC CTWSP FP WFC.WS HCS.PRB CTWSO SAFRY RDS.B UL RDS.A UNP UN CMCSA MA GSK 0005 SAF CCV.CL RHHBY KHC HSEA HSEB DNOW UNF
Following the Great Depression, a series of acts were passed to better regulate the securities markets, financial industry and banks. The most well known to the public of these acts was the Glass-Steagall Act, which separated commercial banking from investment banking. There wasn't another financial crisis until 2008.
WFCNP STT.PRC NTRSP STT.PRE STT.PRD STT.PRG WFC.PRL WFC.PRJ USB BAC WFC.PRT WFC.PRR WFC.PRQ WFC.PRP NTRS WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC STT WFC.WS BAC C BRK.A
Federal Deposit Insurance Corporation (FDIC)-insured commercial banks and savings institutions reported first-quarter 2018 earnings of $56 billion, up 27.5% year over year. Notably, community banks, constituting 92% of all FDIC-insured institutions, reported net income of $6.1 billion, up 17.7% on a year-over-year basis. Banks’ earnings were driven by higher net operating revenues and a lower effective tax rate.
BAC USB TAPOF BAC TPOYY TOL C TAP
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
2018-06-18 - Asif
Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...
Silicon Investor Message Boards
This table lists all message boards related to USB / U.S. Bancorp on message board site Silicon Investor.
|US BANK CORP||USBL (United States Basketball League)|
|Whou0027s Guiltier?-- Andrea Yates or her Husband?||USBL|
|USB - US Bancorp / US Bank / USBank.com||FUNTU CCWW USBR|
|ACAP name change - now USA Biomass Corp. (USBC)|
as of ET